Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Absorbable Hemostats Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_
The absorbable hemostats market size has seen robust growth in recent years. It is projected to increase from $3.37 billion in 2025 to $3.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. This growth in the past can be attributed to an expanding volume of neurosurgery and orthopedic surgery procedures, a heightened demand for products controlling intraoperative bleeding, the increasing uptake of oxidized regenerated cellulose and gelatin-based hemostats, the development of hospital surgical infrastructure and operating rooms, and greater clinical endorsement of absorbable biomaterial hemostats._x000D_
_x000D_
The absorbable hemostats market is expected to demonstrate robust expansion in the foreseeable future. Its value is projected to reach $4.96 billion in 2030, driven by a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period can be attributed to several factors: increased adoption of advanced thrombin and collagen-based formulations, a growing inclination towards minimally invasive and reconstructive surgical procedures, heightened investment in the development of bioabsorbable and hybrid hemostat innovations, an expansion in the volume of procedures performed at ambulatory surgical centers, and an increased focus on minimizing surgical complications and accelerating patient recovery. Significant trends expected in this period include the development of more bioengineered absorbable hemostat materials for enhanced tissue compatibility, the rising integration of advanced collagen, gelatin, and thrombin-based hemostats in complex surgical interventions, a growing preference for multifunctional hemostatic products that support rapid clot stabilization and wound healing, an expanding application of absorbable hemostats in minimally invasive and reconstructive surgeries, and an intensified clinical emphasis on hemostats designed to reduce post-operative complications and surgical bleeding risks._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Absorbable Hemostats Market Growth Catalysts And Demand Drivers#_x000D_
The increasing number of surgical procedures is anticipated to fuel the expansion of the absorbable hemostats market in the future. Surgical procedures involve medical operations conducted to treat, diagnose, or manage health conditions by physically altering tissues or organs through incisions or other methods. This rise in surgical procedures is attributed to a growing demand for advanced medical treatments, an aging global population, and progress in surgical technology enabling more complex and less invasive operations. Absorbable hemostats are utilized in surgical procedures to manage bleeding and encourage clot formation, while being progressively absorbed by the body, thus reducing the need for additional interventions and minimizing postoperative complications. For example, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a professional organization based in the UK, a total of 25,972 surgical procedures were performed in 2023, with women accounting for 93% of all cosmetic surgeries and men comprising the remaining 7% of these cases. Therefore, the growing volume of surgical procedures is a primary driver for the growth of the absorbable hemostasis market._x000D_
_x000D_
#Absorbable Hemostats Market Segment Analysis Spotlighting Growth Areas#_x000D_
The absorbable hemostats market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types_x000D_
2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications_x000D_
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats _x000D_
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products _x000D_
3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats _x000D_
4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder_x000D_
5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations_x000D_
_x000D_
#Absorbable Hemostats Market Trends Shaping Long-Term Demand#_x000D_
Leading companies in the absorbable hemostats market are concentrating on developing advanced products, such as absorbable hemostatic powder, to deliver swift and effective bleeding management during surgery. This absorbable hemostatic powder is a medical product utilized to control hemorrhage by encouraging rapid clot formation at the injury site, and it is naturally assimilated by the body after serving its purpose. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, introduced PERCLOT absorbable hemostatic powder. PERCLOT granules feature a unique molecular structure that quickly absorbs water, creating a gelled adhesive matrix that forms a mechanical barrier to stop bleeding by fostering the aggregation of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This attribute enhances clinicians’ capability to manage a wider array of intraoperative bleeding, which is vital for reducing the necessity for blood transfusions, minimizing significant complications, and ultimately decreasing the overall cost of care._x000D_
_x000D_
#Absorbable Hemostats Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc. _x000D_
_x000D_
#View The Full Absorbable Hemostats Market Report:#_x000D_
_x000D_
#Absorbable Hemostats Market Leading Geography: Which Region Contributes The Most Revenue?#_x000D_
North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
